2025-06-05 • PR Newswire
Akeso's PD-1/CTLA-4 Bispecific Antibody Cadonilimab Approved for First-Line Treatment of Cervical Cancer in All-Comer Populations--Third Approved Indication for Cadonilimab
2025-06-05 • PR Newswire
Akeso's PD-1/CTLA-4 Bispecific Antibody Cadonilimab Approved for First-Line Treatment of Cervical Cancer in All-Comer Populations--Third Approved Indication for Cadonilimab2025-06-05 • PR Newswire
Innovent's IBI363 (PD-1/IL-2α-bias Bispecific Antibody Fusion Protein) Receives Second NMPA Breakthrough Therapy Designation for Immuno-resistant Squamous Non-Small Cell Lung Cancer2025-06-04 • businesswire.com
Avenzo Therapeutics Initiates Phase 1/2 Clinical Study of AVZO-1418, a Potential Best-in-Class, Novel EGFR/HER3 Bispecific Antibody-Drug Conjugate2025-06-04 • PR Newswire
2025 ASCO Oral Presentation: Innovent Biologics Announces Updated Data of IBI363 (First-in-class PD-1/IL-2α-bias Bispecific Antibody Fusion Protein) from the Phase 1 PoC Clinical Study in Advanced Non-small Cell Lung Cancer2025-06-03 • thepharmaletter.com
BMS acquires rights to BioNTech’s bispecific antibody candidate BNT3272025-06-03 • stocktitan.net
BioNTech and Bristol Myers Squibb Announce Global Strategic Partnership to Co-Develop and Co-Commercialize Next-generation Bispecific Antibody Candidate BNT327 Broadly for Multiple Solid Tumor Types2025-06-02 • PR Newswire
2025 ASCO Oral Presentation: Innovent Biologics Announces Updated Date of IBI363 (First-in-class PD-1/IL-2α-bias Bispecific Antibody Fusion Protein) from Phase 1 Clinical Studies in Advanced Colorectal Cancer2025-06-01 • PR Newswire
ASCO 2025 Oral Presentation: Innovent Biologics Announces Updated Data of IBI363 (First-in-class PD-1/IL-2α -bias Bispecific Antibody Fusion Protein) from Phase 1 and 2 Clinical Studies on Immunotherapy-treated Advanced Malignant Melanoma2025-05-30 • PR Newswire
Bambusa Therapeutics Announces First Subject Dosed in Phase 1 Clinical Trial of BBT002, A Novel Platform-In-A-Molecule Bispecific Antibody for Broad I&I Conditions and U.S. FDA Clearance of IND Application for BBT0012025-05-24 • globenewswire.com
Instil Bio and ImmuneOnco to Host Investor and Analyst Breakfast to Discuss the Evolving PD-(L)1xVEGF Bispecific Antibody Landscape and Clinical Trial Updates During the 2025 ASCO Annual Meeting in Chicago2025-05-23 • PR Newswire
FDA Clearance of Investigational New Drug Application Received for Novel EGFR/HER3 Bispecific Antibody-Drug Conjugate AVZO-1418/DB-14182025-05-22 • pmlive.com
Pfizer gains rights to 3SBio’s investigational bispecific antibody in deal worth over $6bn2025-05-22 • globenewswire.com
Instil Bio and ImmuneOnco Announced the Phase 2 Trial in First-line NSCLC of IMM2510/AXN-2510 (‘2510), a PD-L1xVEGF Bispecific Antibody, in Combination with Chemotherapy in China is on Track to Complete Enrollment in Q3 2025; Initial Results Anticipated in 2H 20259 minutes ago • prnewswire.co.uk
Elton John AIDS Foundation launches pilot schemes to accelerate access to Pre-Exposure Prophylaxis (PrEP) and reduce new HIV transmissions in England2 hours ago • investorbrandnetwork.com
Rezolve Ai (NASDAQ: RZLV) Featured in Coverage of ROTH’s 15th Annual London Conference2 hours ago • greennrgstocks.com
SolarBank Corp. (NASDAQ: SUUN) (Cboe CA: SUNN) (FSE: GY2) Among Early Adopters of Bitcoin Treasury Strategies Amid Growing Trend2 hours ago • investorwire.com
Aegis Capital Corp. Announces Completion of $4.3 Million Public Offering for Stardust Power (NASDAQ: SDST)2 hours ago • biomedwire.com
Telomir Pharmaceuticals (NASDAQ: TELO) Reports Preclinical Success for Telomir-1 in Progeria Cell Lines2 hours ago • miningnewswire.com
Platinum Group Metals Ltd. (NYSE American: PLG) (TSX: PTM) Advances Waterberg Project Amid Third Straight Year of Platinum Deficits3 hours ago • prnewswire.co.uk
HD Hyundai Accelerates Entry into European Market with Fuel Cell Technology for Cruise Ships8 hours ago • newswire.ca
Cogeco and Cogeco Communications Schedule the Release of their Financial Results for the Third Quarter of Fiscal 2025 and Related Conference Call9 hours ago • newswire.ca
FortisBC gas bills to change for customers July 110 hours ago • newswire.ca
Fms Capital Trust Files Preliminary Prospectus for Initial Public Offering12 hours ago • travelandtourworld.com
Jump Air Propels Green Aviation Forward with Landmark Deal for Twenty AURA AERO Hybrid-Electric ERA Aircraft at Paris Air Show to Propel Regional Air Travel12 hours ago • medicaldesignandoutsourcing.com
Medtech CDMO VitalPath names permanent CFO2 hours ago • biomedwire.com
Soligenix Inc. (NASDAQ: SNGX) Proprietary Therapy Shows Promise in Treatment of Psoriasis2 hours ago • investorwire.com
Aegis Capital Corp. Announces Completion of $4.3 Million Public Offering for Stardust Power (NASDAQ: SDST)2 hours ago • biomedwire.com
Telomir Pharmaceuticals (NASDAQ: TELO) Reports Preclinical Success for Telomir-1 in Progeria Cell Lines14 hours ago • business-standard.com
Eu Plans Legally Binding Ban On Russian Gas Imports By End Of 202714 hours ago • eunews.it
EU will ban all gas and oil import contracts from Russia by the end of 202716 hours ago • euractiv.com
Brussels proposes total ban on Russian natural gas imports12 hours ago • saurenergy.com
Bright Future for Dark Pits: Turning Abandoned Coal Mines into Solar Powerhouses12 hours ago • deccanherald.com
Repurposing closed coal mines to generate solar power can add 15% to global capacity12 hours ago • indiatoday.in
Nigerian national caught with drugs worth Rs 1.2 crore in Bengaluru raid9 minutes ago • prnewswire.co.uk
Elton John AIDS Foundation launches pilot schemes to accelerate access to Pre-Exposure Prophylaxis (PrEP) and reduce new HIV transmissions in England2 hours ago • investorbrandnetwork.com
Rezolve Ai (NASDAQ: RZLV) Featured in Coverage of ROTH’s 15th Annual London Conference6 hours ago • EIN Presswire
Mini Trader Expands with New MINI Parts Marketplace, Creating a One-Stop Platform for Owners and EnthusiastsStay ahead with real-time headlines from top sources, categorized by sector and country.